RRP36 Antibody

What is RRP36 and why is it important in ribosome biogenesis research?

RRP36 is an essential nucleolar protein that plays a crucial role in ribosome biogenesis, specifically in the early cleavage events of pre-rRNA processing. It functions as a component of the 90S preribosome and interacts with both 90S and pre-40S preribosomal particles . The significance of RRP36 lies in its evolutionary conservation across eukaryotes, suggesting a fundamental role in ribosome assembly pathways .

When investigating ribosome assembly defects, RRP36 serves as an excellent marker because its depletion leads to rapid and specific decrease in mature 18S rRNA levels, providing a clear phenotype that can be measured experimentally . For researchers studying fundamental cellular processes, understanding RRP36 function offers insights into the complex regulatory mechanisms controlling ribosome production.

When extracting RRP36 protein for antibody-based experiments, consider its nucleolar localization and association with large ribosomal complexes. The following methodology optimizes RRP36 extraction:

• Nuclear extraction approach:

  • Use a fractionation protocol to separate cytoplasmic and nuclear components

  • For nucleolar proteins like RRP36, standard RIPA buffer may be insufficient

  • Consider specialized nuclear extraction buffers containing 420-450 mM NaCl to disrupt nucleolar structures

• Lysis buffer optimization:

  • Base buffer: 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40

  • Add 0.5% sodium deoxycholate and 0.1% SDS for enhanced solubilization

  • Include protease inhibitors and phosphatase inhibitors to prevent degradation

  • Add 1-5 mM MgCl₂ to stabilize ribosomal complexes

• Sonication parameters:

  • Brief sonication (3-5 pulses, 10 seconds each at 30% amplitude)

  • Keep samples on ice between pulses to prevent protein degradation

Since RRP36 associates with large preribosomal complexes, standard protein extraction methods may need modification to maximize yield while maintaining protein integrity .

How can I validate the specificity of my RRP36 antibody?

Antibody validation is critical for ensuring experimental reliability. For RRP36 antibodies, implement the following methodological approach:

• Positive and negative controls:

  • Positive control: Tissue/cells known to express RRP36 (most proliferating cells)

  • Negative control: RRP36-depleted samples through siRNA/shRNA knockdown

  • Include a blocking peptide control if available

• Multiple technique validation:

  • Western blot should show a single band at the expected molecular weight (~36-40 kDa)

  • Immunofluorescence should demonstrate nucleolar localization patterns

  • Compare results with published localization patterns

• Cross-validation with orthogonal methods:

  • Compare protein detection with mRNA expression (RT-qPCR)

  • Consider mass spectrometry identification of immunoprecipitated proteins

  • Use tagged versions of RRP36 (if available) to compare with antibody staining patterns

The most rigorous validation includes demonstration of signal loss in genetic knockout or knockdown systems, combined with signal detection at the expected subcellular location and molecular weight .

What approaches can be used to investigate RRP36 interactions with preribosomal particles?

Investigating RRP36 interactions with preribosomal particles requires specialized techniques that preserve complex integrity. Consider this methodological framework:

• Co-immunoprecipitation (Co-IP) with gradient analysis:

  • Use mild detergents (0.1% NP-40) to preserve ribosomal complexes

  • Consider crosslinking with formaldehyde (1% for 10 minutes) before lysis

  • Perform immunoprecipitation with RRP36 antibodies

  • Analyze associated RNAs by northern blotting for pre-rRNA species

  • Identify protein partners by mass spectrometry

• Sucrose gradient fractionation:

  • Prepare nuclear extracts under non-denaturing conditions

  • Separate complexes on 10-50% sucrose gradients (16 hours, 21,000 rpm)

  • Collect fractions and analyze by western blotting for RRP36

  • Compare RRP36 sedimentation with known 90S and pre-40S markers

• Proximity labeling approaches:

  • Generate BioID or TurboID fusions with RRP36

  • Express in relevant cell lines and provide biotin

  • Purify biotinylated proteins and identify by mass spectrometry

  • Validate interactions through reciprocal tagging experiments

Research has established that Rrp36p interacts with both 90S and pre-40S preribosomal particles, and its recruitment depends on components of the UTP-A and UTP-B modules but not Rrp5p . These interactions are critical for understanding its role in the hierarchical assembly of the 90S preribosome.

How can I design experiments to study the evolutionary conservation of RRP36 function?

To study evolutionary conservation of RRP36 function across species, a comprehensive approach combining multiple techniques is recommended:

• Comparative sequence analysis protocol:

  • Obtain RRP36 sequences from diverse eukaryotic species

  • Perform multiple sequence alignment using CLUSTALW or MUSCLE

  • Identify conserved domains and critical residues

  • Generate phylogenetic trees to visualize evolutionary relationships

• Complementation studies methodology:

  • Generate yeast strains with conditional RRP36 depletion

  • Express RRP36 orthologs from different species (human, mouse, etc.)

  • Assess rescue of growth defects and pre-rRNA processing

  • Quantify 18S rRNA levels by northern blotting or RT-qPCR

• Localization comparison approach:

  • Express tagged versions of RRP36 orthologs in heterologous systems

  • Perform immunofluorescence to determine nucleolar localization

  • Compare interaction partners through immunoprecipitation studies

  • Analyze protein domains required for proper localization

Studies have demonstrated that the human orthologue of yeast Rrp36p maintains the conserved function in early cleavages of pre-rRNA, suggesting fundamental evolutionary conservation of this protein's role in ribosome biogenesis . This conservation makes RRP36 an excellent model for studying core eukaryotic cellular processes.

What are the challenges in detecting low-abundance RRP36 in differentiated cell types?

Detecting low-abundance RRP36 in differentiated cells presents several technical challenges requiring specialized approaches:

• Enhanced sensitivity protocols:

  • Signal amplification: Use tyramide signal amplification (TSA) for immunohistochemistry

  • Concentrate protein samples through immunoprecipitation before western blotting

  • Employ high-sensitivity detection reagents (ECL Prime/Femto)

  • Consider ddPCR for accurate transcript quantification

• Specificity enhancement strategies:

  • Use multiple validated antibodies targeting different epitopes

  • Implement blocking steps with albumin, casein or commercial blockers

  • Increase antibody incubation time (overnight at 4°C) while decreasing concentration

  • Include extensive washing steps to reduce background

• Subcellular enrichment methodology:

  • Perform nucleolar isolation to concentrate RRP36

  • Use sucrose gradient fractionation to isolate ribosomal fractions

  • Consider proximity ligation assay (PLA) for detecting protein interactions at endogenous levels

Differentiated cells typically show reduced ribosome biogenesis activity compared to proliferating cells, resulting in lower RRP36 expression. Consider using nucleolar markers like fibrillarin as positive controls to validate nucleolar integrity in your samples .

How do I reconcile contradictory results from different RRP36 antibodies?

When facing contradictory results from different RRP36 antibodies, implement this systematic troubleshooting approach:

• Epitope mapping analysis:

  • Determine the epitope regions recognized by each antibody

  • Check for potential post-translational modifications that might affect epitope accessibility

  • Consider potential isoform specificity of different antibodies

  • Assess whether antibodies recognize denatured vs. native conformations

• Technical validation protocol:

  • Compare antibody performance across multiple technical replicates

  • Standardize protein loading, transfer conditions, and detection methods

  • Test antibodies at multiple dilutions (1:500, 1:1000, 1:2000, etc.)

  • Perform side-by-side comparisons under identical conditions

• Orthogonal validation approach:

  • Employ genetic models (siRNA, CRISPR) to create control samples

  • Use epitope-tagged constructs to validate endogenous protein detection

  • Compare antibody results with RNA expression data from RNA-seq

  • Consider mass spectrometry-based validation of target identification

The polyclonal nature of most available RRP36 antibodies (as seen in the table in section 1.2) may contribute to variability in results . When possible, prioritize antibodies with multiple independent validations and published research applications.

What experimental designs can elucidate RRP36's role in pre-rRNA processing pathways?

To investigate RRP36's specific role in pre-rRNA processing, consider these methodological approaches:

• Conditional depletion system design:

  • Generate auxin-inducible degron (AID)-tagged RRP36 cell lines

  • Establish tetracycline-regulated expression systems

  • Create temperature-sensitive mutants in yeast models

  • Design time-course experiments with samples collected at multiple timepoints

• Pre-rRNA processing analysis protocol:

  • Extract total RNA using TRIzol or similar reagents

  • Perform northern blotting with probes targeting specific pre-rRNA regions

  • Use pulse-chase labeling with 5,6-³H-uridine to track nascent rRNA synthesis

  • Implement RT-qPCR with primers spanning processing sites

• Molecular interaction mapping methodology:

  • Perform CLIP-seq to identify direct RNA binding sites

  • Use chromatin immunoprecipitation to assess potential chromatin association

  • Implement BioID or proximity labeling to identify protein interaction partners

  • Develop in vitro cleavage assays with purified components

Research has established that RRP36 depletion specifically affects early cleavages of the 35S pre-rRNA, resulting in decreased 18S rRNA levels while not impairing the incorporation of other processing factors like the tUTP/UTP-A, PWP2/UTP-B, and UTP-C subcomplexes into preribosomes . This suggests RRP36 functions downstream of these factors but is still critical for early processing events.

How can I optimize immunofluorescence protocols for detecting nucleolar RRP36?

Optimizing immunofluorescence for nucleolar RRP36 detection requires special consideration due to its localization and relatively low abundance:

• Fixation optimization:

  • Compare paraformaldehyde (4%, 10 min) vs. methanol (-20°C, 5 min)

  • Test hybrid fixation: PFA followed by methanol for epitope accessibility

  • Consider adding 0.1-0.5% Triton X-100 during fixation to enhance nuclear penetration

  • Evaluate need for antigen retrieval (citrate buffer, pH 6.0, 95°C, 10 min)

• Signal enhancement methodology:

  • Implement tyramide signal amplification (TSA) for weak signals

  • Use high-sensitivity detection systems (quantum dots or similar)

  • Optimize antibody concentration through titration experiments

  • Extend primary antibody incubation (overnight at 4°C) with lower concentration

• Co-localization assessment protocol:

  • Include established nucleolar markers (fibrillarin, nucleolin)

  • Use DNA counterstains to visualize nuclei (DAPI or Hoechst)

  • Implement multi-channel confocal microscopy for precise localization

  • Quantify co-localization using Pearson's or Mander's coefficients

Nucleolar proteins often require specialized permeabilization steps due to the dense structure of the nucleolus. Consider additional permeabilization with 0.5% Triton X-100 for 10 minutes after fixation to improve antibody penetration .

What controls are essential when studying RRP36 in ribosome biogenesis assays?

When designing ribosome biogenesis assays involving RRP36, implement these critical controls:

• Technical control methodology:

  • Include loading controls targeting stable housekeeping proteins

  • Prepare positive controls with known ribosome biogenesis factors

  • Implement negative controls through non-targeting siRNAs or scrambled sequences

  • Include mock-transfected or untreated samples as baseline references

• Functional validation controls:

  • Monitor cell growth/proliferation to detect gross defects

  • Assess global protein synthesis rates (puromycin incorporation)

  • Measure nucleolar stress markers (p53 levels, nucleolar disruption)

  • Quantify mature rRNA levels as functional readout

• Specificity controls protocol:

  • Perform rescue experiments with siRNA-resistant constructs

  • Include depletion of known processing factors as positive controls

  • Assess multiple pre-rRNA processing intermediates, not just final products

  • Examine effects on parallel processing pathways as specificity controls

Research has established that components of UTP-A or UTP-B modules are required for RRP36 recruitment and stability . Including these factors as positive controls in your experiments provides valuable benchmarks for comparison.

How can RRP36 antibodies be used in studying cancer cell ribosome biogenesis?

Using RRP36 antibodies to study aberrant ribosome biogenesis in cancer cells requires specialized approaches:

• Cancer cell line panel analysis:

  • Select diverse cancer cell lines representing multiple tissue origins

  • Quantify RRP36 protein levels via western blotting with standardized loading

  • Compare nucleolar morphology and RRP36 localization via immunofluorescence

  • Correlate RRP36 levels with proliferation rates and ribosome production

• Patient sample methodology:

  • Develop tissue microarray (TMA) immunohistochemistry protocols

  • Compare RRP36 expression between tumor and adjacent normal tissue

  • Implement dual staining with proliferation markers (Ki-67)

  • Score nucleolar size/number alongside RRP36 expression

• Therapeutic response assessment:

  • Monitor RRP36 levels/localization after treatment with ribosome biogenesis inhibitors

  • Track changes in pre-rRNA processing patterns following treatment

  • Assess correlation between RRP36 levels and treatment sensitivity

  • Develop combination approaches targeting RRP36-dependent pathways

Cancer cells typically exhibit upregulated ribosome biogenesis to support their increased protein synthesis demands. RRP36 antibodies can serve as valuable tools for assessing nucleolar activity and ribosome production rates in these contexts .

How should I quantify and normalize RRP36 protein levels across different experimental conditions?

Proper quantification and normalization of RRP36 protein levels requires rigorous methodology:

• Western blot quantification protocol:

  • Use digital image capture systems instead of film

  • Ensure exposure times avoid signal saturation

  • Implement technical replicates (minimum n=3)

  • Analyze band intensity using ImageJ or similar software

• Normalization approach:

  • Select appropriate loading controls (β-actin, GAPDH, α-tubulin)

  • Consider nucleolar-specific normalizers (fibrillarin, nucleolin) for subcellular specificity

  • Use total protein normalization (Ponceau, REVERT, etc.) to avoid single-protein biases

  • Calculate relative expression as RRP36/normalizer ratio

• Statistical analysis methodology:

  • Apply appropriate statistical tests (t-test, ANOVA)

  • Present data with error bars representing standard deviation or SEM

  • Consider non-parametric tests if data doesn't follow normal distribution

  • Implement correction for multiple comparisons when needed

For immunofluorescence quantification, measure nucleolar RRP36 intensity relative to nucleolar area or volume, and normalize to nucleolar markers to account for changes in nucleolar structure across conditions .

What are the best practices for integrating RRP36 data with broader ribosome assembly pathway analysis?

To effectively integrate RRP36 data with broader ribosome assembly pathway analysis:

• Multi-omics integration approach:

  • Compare RRP36 protein levels with transcriptome data

  • Correlate RRP36 activity with rRNA processing intermediates

  • Analyze RRP36 interaction partners through proteomics

  • Map RRP36 function within established ribosome assembly networks

• Temporal analysis methodology:

  • Implement time-course experiments following RRP36 depletion/overexpression

  • Track sequential changes in pre-rRNA intermediates

  • Monitor assembly/disassembly of preribosomal complexes

  • Develop mathematical models of processing kinetics

• Functional clustering protocol:

  • Group factors with similar depletion phenotypes

  • Classify based on affected pre-rRNA processing steps

  • Compare interaction networks of functionally related factors

  • Develop hierarchical models of interdependence

Research has established that RRP36 functions in the context of the 90S preribosome assembly, where its recruitment depends on specific modules like UTP-A and UTP-B . Understanding these relationships helps position RRP36 within the broader ribosome assembly pathway and interpret experimental results accordingly.

What emerging technologies might enhance our ability to study RRP36 function?

Several emerging technologies show promise for advancing RRP36 research:

• CRISPR-based approaches:

  • Generate endogenously tagged RRP36 cell lines using CRISPR knock-in

  • Implement CRISPRi for controlled, partial knockdown experiments

  • Develop CRISPR activation systems to study overexpression effects

  • Apply base editing to introduce specific mutations without disrupting expression

• Advanced imaging methodologies:

  • Implement super-resolution microscopy (STORM, PALM) for nucleolar organization

  • Apply live-cell imaging with split fluorescent proteins to track interactions

  • Use lattice light-sheet microscopy for dynamic studies

  • Develop FRET/FLIM approaches to measure direct protein-protein interactions

• Single-cell analysis protocols:

  • Apply single-cell RNA-seq to capture heterogeneity in response to RRP36 perturbation

  • Implement CITE-seq to correlate protein and RNA levels

  • Develop spatial transcriptomics approaches for tissue-level analysis

  • Use mass cytometry for multi-parametric single-cell protein analysis

Future research directions could focus on understanding how RRP36 function is regulated in response to cellular stress and nutrient availability, potentially uncovering new regulatory mechanisms in ribosome biogenesis .

How can researchers address the challenges of studying RRP36 in primary tissues?

Studying RRP36 in primary tissues presents unique challenges that can be addressed through these methodological approaches:

• Tissue processing optimization:

  • Test multiple fixation protocols (formalin, frozen sections)

  • Optimize antigen retrieval methods for different tissue types

  • Consider specialized extraction buffers for different tissues

  • Implement laser capture microdissection for cell-type specific analysis

• Signal detection enhancement:

  • Apply multiplexed immunofluorescence with spectral unmixing

  • Implement rolling circle amplification for weak signals

  • Use quantum dot conjugated secondary antibodies for improved sensitivity

  • Consider chromogenic multiplexing for tissue samples

• Validation strategy:

  • Compare antibody performance across multiple tissue preparation methods

  • Include positive control tissues with known high RRP36 expression

  • Correlate protein detection with RNA expression through RNAscope

  • Develop spatial proteomics approaches for complex tissues

Primary tissues often contain heterogeneous cell populations with varying levels of ribosome biogenesis activity. Consider cell-type specific markers to correlate RRP36 expression with particular cell populations within complex tissues .